Treatment of bladder pain syndrome and... (2016 study) Skip to main content
Systematic Review Int Urogynecol J 2016

Treatment of bladder pain syndrome and interstitial cystitis: a systematic review

Pazin C, de Souza Mitidieri A, Silva A, Gurian M, Poli-Neto O, Rosa-E-Silva J, Int Urogynecol J, 2016

Tier 1, Curated

Manually reviewed and included in the Canada Hyperbarics research database.

Summary

What Researchers Did

The researchers searched medical databases for studies published between 1990 and 2014 on treatments for bladder pain syndrome and interstitial cystitis (BPS/IC) and reviewed how well each treatment worked.

What They Found

This systematic review found that existing studies could not define the best treatment for BPS/IC, because no treatment had at least two randomized controlled trials available for meta-analysis. Of 356 articles found, 13 were included. The treatments studied were hyaluronic acid instillation, botulinum toxin A, intravesical lidocaine, hyperbaric chamber, massage, physiotherapy, phosphate-buffered saline, piroxicam combined with doxepin, and others. Symptoms were most often measured with the visual analogue scale, voiding record, and the O'Leary-Sant questionnaire.

What This Means for Canadian Patients

For people with BPS/IC, the review found no standardized treatment and no clear best option. A hyperbaric chamber was one of the many approaches included, but the abstract gives no results, pressure, or session numbers for it, so it does not show whether hyperbaric treatment helps this condition. Patients should talk with their own doctor about their options.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The authors say the studies they reviewed varied widely in the treatments used and were of limited methodological quality, so no treatment could be compared in a meta-analysis and studies with better methods are needed.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Systematic Review
Category Systematic Reviews
Source Pubmed
PubMed ID 26272202
Year Published 2016
Journal Int Urogynecol J
MeSH Terms Acetylcholine Release Inhibitors; Adjuvants, Immunologic; Administration, Intravesical; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Botulinum Toxins, Type A; Cystitis, Interstitial; Drug Therapy, Combination; Female; Humans; Hyaluronic Acid; Hyperbaric Oxygenation; Lidocaine; Pentosan Sulfuric Polyester; Physical Therapy Modalities; Sodium Chloride

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 17, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology